P03.01 A Randomized Phase II Trial of Adjuvant Pembrolizumab vs Observation after Curative Resection for Stage I NSCLC with Primary Tumors Between 1-4 cm

G. Durm; T. Birdas; H. Liu; S. Jalal; K. Kesler; K. Rieger; D. Ceppa; N. Hanna

doi:10.1016/j.jtho.2021.01.374

P03.01 A Randomized Phase II Trial of Adjuvant Pembrolizumab vs Observation after Curative Resection for Stage I NSCLC with Primary Tumors Between 1-4 cm

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.374 ◽

2021 ◽

Vol 16 (3) ◽

pp. S257-S258

Author(s):

G. Durm ◽

T. Birdas ◽

H. Liu ◽

S. Jalal ◽

K. Kesler ◽

...

Keyword(s):

Phase Ii ◽

Curative Resection ◽

Phase Ii Trial ◽

Stage I ◽

Primary Tumors ◽

Randomized Phase Ii

Download Full-text

Randomized phase II trial of anthracycline-free and anthracycline-containing neoadjuvant carboplatin chemotherapy regimens in stage I-III triple-negative breast cancer (NeoSTOP)

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-20-3646 ◽

2020 ◽

pp. clincanres.3646.2020

Author(s):

Priyanka Sharma ◽

Bruce F Kimler ◽

Anne P O'Dea ◽

Lauren Nye ◽

Yen Y Wang ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase Ii Trial ◽

Stage I ◽

Randomized Phase Ii

Download Full-text

Randomized phase II trial of CAPOX with planned oxaliplatin stop-and-go strategy as adjuvant chemotherapy after curative resection of colon cancer (CCOG-1302 study)

Annals of Oncology ◽

10.1093/annonc/mdz246.050 ◽

2019 ◽

Vol 30 ◽

pp. v216

Author(s):

H. Yokoyama ◽

G. Nakayama ◽

K. Ishigure ◽

N. Hayashi ◽

K. Tanaka ◽

...

Keyword(s):

Colon Cancer ◽

Adjuvant Chemotherapy ◽

Phase Ii ◽

Curative Resection ◽

Phase Ii Trial ◽

Stop And Go ◽

Randomized Phase Ii

Download Full-text

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage

Journal of Hepatology ◽

10.1016/j.jhep.2008.12.023 ◽

2009 ◽

Vol 50 (5) ◽

pp. 958-968 ◽

Cited By ~ 101

Author(s):

Chun-Jen Liu ◽

Po-Huang Lee ◽

Deng-Yn Lin ◽

Cheng-Chung Wu ◽

Long-Bin Jeng ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Adjuvant Therapy ◽

Phase Ii ◽

Curative Resection ◽

Phase Ii Trial ◽

Optimal Dosage ◽

Randomized Phase Ii

Download Full-text

1400: A Randomized Phase II Trial Evaluating the Importance of Early Erectile Dysfunction Rehabilitation and Unilateral Autologous Sural Nerve Grafting in Patients Undergoing a Unilateral Cavernous Nerve Sparing Radical Prostatectomy for Clinically localized PR

The Journal of Urology ◽

10.1016/s0022-5347(18)31601-x ◽

2007 ◽

Vol 177 (4S) ◽

pp. 461-461 ◽

Cited By ~ 1

Author(s):

Christopher G. Wood ◽

David Chang ◽

Run Wang ◽

Yu Shen ◽

Curtis A. Pettaway ◽

...

Keyword(s):

Erectile Dysfunction ◽

Radical Prostatectomy ◽

Phase Ii ◽

Sural Nerve ◽

Phase Ii Trial ◽

Nerve Sparing ◽

Nerve Grafting ◽

Cavernous Nerve ◽

Randomized Phase Ii

Download Full-text

RANDOMIZED PHASE II TRIAL OF CARBOPLATIN-PACLITAXEL COMPARED TO CARBOPLATIN-PACLITAXEL-TRASTUZUMAB IN ADVANCED (STAGE III-IV) OR RECURRENT UTERINE SEROUS CARCINOMA: RESULTS OF INTERIM ANALYSIS (NCT01367002)

10.26226/morressier.5770e29bd462b80290b4bae3 ◽

2016 ◽

Author(s):

Alessandro D Santin

Keyword(s):

Phase Ii ◽

Interim Analysis ◽

Phase Ii Trial ◽

Stage Iii ◽

Serous Carcinoma ◽

Advanced Stage ◽

Randomized Phase Ii ◽

Uterine Serous Carcinoma

Download Full-text

Faculty Opinions recommendation of A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697918.793457734 ◽

2012 ◽

Author(s):

Hans-Joachim Schmoll

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

Dose Dense ◽

First Line Treatment

Download Full-text

Faculty of 1000 evaluation for Automated sedation outperforms manual administration of propofol and remifentanil in critically ill patients with deep sedation: a randomized phase II trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717969496.793472190 ◽

2013 ◽

Author(s):

Andreas Hoeft

Keyword(s):

Critically Ill ◽

Phase Ii ◽

Critically Ill Patients ◽

Phase Ii Trial ◽

Deep Sedation ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718144304.793486590 ◽

2013 ◽

Author(s):

Roberto Angioli

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Pegylated Liposomal Doxorubicin ◽

Platinum Resistant ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718151420.793488671 ◽

2013 ◽

Author(s):

Brian Keith Bednarski

Keyword(s):

Rectal Cancer ◽

High Risk ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of Randomized phase II trial of ridaforolimus in advanced endometrial carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725563727.793527269 ◽

2017 ◽

Author(s):

Paola Gehrig

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Randomized Phase Ii

Download Full-text